Pureos BioVentures pulls in $205m to close debut drug developer-focused fund

7
Pureos Bioventures has hit a $205m final close for its debut fund, which will look to back developers of novel biologica
Sorry, you need to subscribe to read this article.
If you would like to access this article you must become a
Premium Subscriber.
Premium subscribers receive complete access to our daily breaking news, premium stories, weekly Fundraising & IR Review, Knowledge Bank and LP profiles - all which are accessible via our mobile platform.

Related Keywords

Switzerland ,Swiss ,Dominik Escher ,Anja Harmeier ,Pureos Bioventures ,Klaus Breiner ,River Renal Corp ,Nasdaq ,Alentis Therapeutics ,Corlieve Therapeutics ,சுவிட்சர்லாந்து ,சுவிஸ் ,டோமினிக் எஶர் ,கிளாஸ் ப்ரெய்னர் ,நாஸ்டாக் ,